(Q33737719)

29 July 2017

1 reference

title

An overview of sexually transmitted diseases. Part I. (English)

1 reference

sexually transmitted infection

29 July 2017

0 references

0 references

author name string

Brown TJ

series ordinal

1

1 reference

29 July 2017

Yen-Moore A

series ordinal

2

1 reference

29 July 2017

Tyring SK

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

Journal of the American Academy of Dermatology

29 July 2017

published in

1 reference

29 July 2017

volume

41

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

511-532

1 reference

Sexually transmitted diseases: bacterial infections. Committee on Sexually Transmitted Diseases of the American Academy of Dermatology

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

EPIDEMIOLOGIC TREATMENT OF CONTACTS TO INFECTIOUS SYPHILIS.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Acquired syphilis in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Testing for syphilis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Sexually transmitted diseases update

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Treatment of syphilis, 1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Comparison of methods for the detection of treponema pallidum in lesions of early syphilis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Molecular detection of Treponema pallidum in secondary and tertiary syphilis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Peroxidase-mediated Antimicrobial Activity of Rat Uterine Fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

CUTANEOUS MANIFESTATIONS OF GONOCOCCEMIA. A REVIEW OF 14 CASES.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Cutaneous features of sexually transmitted diseases. Recognition and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Disseminated gonococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Complications of Gonococcal Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Chancroid epidemiology in New Orleans men

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Approach to the patient with genital ulcer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Enhanced recovery of Haemophilus ducreyi from clinical specimens by incubation at 33 versus 35 degrees C.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

A simple medium for the primary isolation of Haemophilus ducreyi

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Chancroid and Haemophilus ducreyi

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Laboratory techniques used in the diagnosis of chancroid, granuloma inguinale, and lymphogranuloma venereum.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Use of dot-immunobinding and immunofluorescence assays to investigate clinically suspected cases of chancroid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Genital ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Epidemiology of sexually transmitted Chlamydia trachomatis infections

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Lymphogranuloma venereum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Chlamydial infections (first of three parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Lymphogranuloma venereum: 27 cases in Paris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Genital ulcer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Laboratory diagnosis of human chlamydial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

1 reference

7 January 2021

Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Problematic ulcerative lesions in sexually transmitted diseases: surgical management

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Growth and cultural characteristics of Calymmatobacterium granulomatis--the aetiological agent of granuloma inguinale (Donovanosis)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

1 reference

7 January 2021

Ultrastructure of Calymmatobacterium granulomatis in Lesions of granuloma inguinale

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Granuloma inguinale of the vagina and cervix uteri with bone metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Granuloma inguinale involving buttock and lymph node; cultivation of the Donovan body in embryonic yolk.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Extragenital granuloma inguinale in North Queensland

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Culture of Calymmatobacterium granulomatis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Culture of the causative organism of donovanosis (Calymmatobacterium granulomatis) in HEp-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Disseminated donovanosis (granuloma inguinale) causing spinal cord compression: case report and review of donovanosis involving bone.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Granuloma inguinale: three cases diagnosed in Toronto, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Genital herpes: natural history and treatment of acute episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Herpes simplex virus type 2 in the United States, 1976 to 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Herpes simplex virus type 2--a persistent problem

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Herpes simplex: evolving concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Genital herpes infection: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Herpes simplex virus-2 infection. An emerging disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Risk Factors for the Sexual Transmission of Genital Herpes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Recurrence rates in genital herpes after symptomatic first-episode infection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Epidemiology of genital herpes in Pittsburgh: serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infections

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Underdiagnosis of Genital Herpes by Current Clinical and Viral-Isolation Procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Inability of Enzyme Immunoassays to Discriminate between Infections with Herpes Simplex Virus Types 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Asymptomatic shedding of herpes simplex virus from the genital tract: uncertainty and its consequences for patient management. The Herpes Simplex Virus Advisory Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Genital herpes simplex virus infections: clinical manifestations, course, and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Recurrent Herpes Simplex in the Mouse: Inflammation in the Skin and Activation of Virus in the Ganglia Following Peripheral Stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Prevention of ultraviolet-light-induced herpes labialis by sunscreen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

The prophylactic use of cyclooxygenase inhibitors in recurrent herpes simplex infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

The effect of prostaglandins on the multiplication and cell-to-cell spread of herpes simplex virus type 2 in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Pharmacokinetics of acyclovir after intravenous and oral administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Oral acyclovir for episodic treatment of recurrent genital herpes. Efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Advances in the treatment of herpesvirus infection: the role of famciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Antiviral chemotherapy in genital herpes simplex virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Herpes. Vaccines for HSV

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

The influence of adjuvant on the therapeutic efficacy of a recombinant genital herpes vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2899%2980045-0

7 January 2021

10.1016/S0190-9622(99)80045-0

Identifiers

DOI

1 reference

29 July 2017

1 reference